Hydrocephalus is a serious, multifactorial neurological disorder that can manifest both in infancy and childhood as well as in adulthood. It is characterized by the abnormal accumulation of cerebrospinal fluid within the brain ventricles, leading to disruption of the normal structure, development, and function of brain tissue. The consequences of the disease are often long-term and significantly affect neurological function, cognitive development, and patients’ overall quality of life.
In this context, the Hydrocephalus Association of the United States has awarded Professor of Physiology Stavros Taraviras the international Innovator Award 2025, in recognition of his innovative and high-impact scientific contributions to hydrocephalus research. This distinction is granted to researchers who demonstrate originality and strong potential for clinical translation, aiming to advance understanding of the disease’s pathophysiology and to foster the development of new therapeutic approaches.
https://www.hydroassoc.org/announcing-the-2025-innovator-award-recipients/
Professor Taraviras’ research proposal focuses on the use of focused ultrasound technologies for targeted gene delivery to the brain, with the aim of restoring molecular and cellular dysfunctions that contribute to the onset and progression of hydrocephalus. This approach falls within the fields of regenerative medicine and gene therapy, and its successful implementation is expected to contribute to the development of non-invasive, innovative, and personalized therapeutic strategies.
About the Hydrocephalus Association
The Hydrocephalus Association is an internationally recognized nonprofit organization dedicated to advancing scientific research, educating healthcare professionals and the public, and improving clinical care and quality of life for individuals living with hydrocephalus. Through funding innovative research programs, supporting patients and families, and promoting international scientific collaboration, the organization plays a pivotal role in advancing knowledge in this field. Notably, this award has been granted to European researchers only twice, underscoring its exceptional prestige; Professor Taraviras was also a recipient of this distinction in 2020.
About Professor Stavros Taraviras
Professor Stavros Taraviras is Professor of Physiology and Director of the Laboratory of Physiology at the Medical School of the University of Patras. He holds a PhD from the Heidelberg University and has extensive postdoctoral research experience at leading research institutions in Germany and the United Kingdom. His scientific work has achieved significant international recognition, with numerous publications in prestigious peer-reviewed journals and active participation in international research networks.
His research team focuses on the study of neural stem cells, particularly on the reprogramming and regeneration of brain ependymal cells, which play a critical role in regulating cerebrospinal fluid circulation and in the pathophysiology of hydrocephalus. This research is conducted within a translational research framework, aiming to translate fundamental scientific discoveries into clinical applications for the benefit of patients.
